Related Experiment Video
Updated: Mar 8, 2026

Research and Development of High-performance Explosives
Published on: February 20, 2016
SIRA+P: Development and Testing
Kristina L Foster1, Lacey D Bergerhofer2, Janis B Smith2
1Lucile Packard Children's Hospital Stanford, 725 Welch Rd, Palo Alto, CA 94304, United States.
Insights
The new Skin Injury Risk Assessment and Prevention (SIRA+P) scale demonstrates high reliability and validity across all ages for assessing skin injury risk. This tool aids nurses in preventing pressure injuries with EHR integration.
Area of Science:
- Nursing
- Patient Safety
- Clinical Assessment Tools
Background:
- Pressure injuries are a significant concern in healthcare, impacting patient outcomes and increasing costs.
- Existing risk assessment scales may have limitations in applicability across diverse age groups and clinical settings.
- The development of a comprehensive and reliable skin risk assessment tool is crucial for effective prevention strategies.
Purpose of the Study:
- To introduce and evaluate the psychometric properties of the Skin Injury Risk Assessment and Prevention (SIRA+P) scale.
- To establish the initial reliability and validity of the SIRA+P scale in a broad patient population, from neonates to adults.
- To assess the SIRA+P scale's utility across various age groups and illness acuities.
Main Methods:
- A retrospective chart review of 385 patients across all hospital units was conducted.
- Concurrent validity was assessed by comparing SIRA+P with established scales: Neonatal Skin Risk Assessment Scale (NSRAS), Braden Q Scale (Braden Q), and Braden Scale.
- Interrater reliability was determined using Intraclass Correlation Coefficients (ICC).
Main Results:
- The SIRA+P scale exhibited very high interrater reliability (ICC = 0.878).
- Strong correlations were found between SIRA+P and established scales: NSRAS (0.725), Braden Q (-0.634), and Braden (-0.778).
- These results indicate good reliability and validity across the studied age spectrum.
Conclusions:
- The SIRA+P scale is a reliable and valid tool for assessing skin injury risk in patients of all ages.
- Designed for EHR integration, SIRA+P offers nursing decision support for targeted pressure injury prevention.
- The scale's ability to account for device-related pressure enhances its clinical utility in preventing skin breakdown.
Objectives:
To describe the development of a new skin risk assessment scale called Skin Injury Risk Assessment and Prevention (SIRA+P) and to establish initial reliability and validity of the scale among patients ranging in age from birth, including pre-term, to adulthood, regardless of age or acuity of illness.
Study Design:
The single-site study was a retrospective chart review to evaluate the measurement properties of SIRA+P. Charts of 385 patients of all ages and in all units (including the neonatal and pediatric intensive care units) of a free-standing children's hospital were included. Concurrent validity was assessed with scales having previously established reliability and validity. For subjects <30days of age, the comparison scale was the Neonatal Skin Risk Assessment Scale (NSRAS); for subjects 31days through 17years, the Braden Q Scale (Braden Q) was used; and for subjects 18years and older, the Braden Scale (Braden) was used. Interrater reliability was examined using Intraclass Correlation Coefficients (ICC). Concurrent validity procedures compared SIRA+P with NSRAS, Braden Q, and Braden using Pearson Correlation Coefficients.
Results:
Interrater reliability for SIRA+P was very high (0.878). SIRA+P strongly correlated with the NSRAS (0.725), the Braden Q (-0.634), and the Braden (-0.778).
Conclusion:
SIRA+P is designed to be used within the EHR and includes nursing decision support to guide pressure injury prevention interventions for specific skin integrity risks. SIRA+P has good interrater reliability, is valid across all age groups and accounts for device-related pressure.
Related Concept Videos
Preclinical Development: Overview
In Vitro Drug Release Testing: Overview, Development and Validation
Quality Assurance
Clinical Trials: Overview
Three Developmental Domains
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
Significance Testing: Overview

